Teladoc ( ($TDOC) ) just unveiled an update. On December 9, 2025, Teladoc Health, Inc. amended its 2023 Employment Inducement Incentive Award Plan ...

HIMS expands its tech-driven care with new diagnostics, hormonal treatments, and a Canada launch via Livewell.

Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term losses from the stock lately, despite its bumpy ride over recent months. The San Francisco, CA-based health and ...

Barclays initiated coverage of Teladoc (TDOC) with an Equal Weight rating and $8.50 price target The firm started the U.S healthcare technology ...